ECT2 and posterior cortical atrophy: In our study, we validated ANLN and ECT2 expression in a separate independent clinical cohort within a high-risk population and reported ECT2 expression is significantly overexpressed in tumors compared to non-malignant tissue and is positively associated with clinicopathological features (i.e., Gleason score) in AA men with PCa.